P. M. Harper and . Dystrophy, , p.436, 2001.

J. Mathieu, D. Braekeleer, M. Prévost, and C. , Genealogical reconstruction of myotonic dystrophy in the Saguenay, Neurology. mai, vol.40, issue.5, pp.839-881, 1990.

H. Steinberg and A. Wagner,

, Nervenarzt. août, vol.79, issue.8, pp.965-70, 2008.

J. D. Brook, M. E. Mccurrach, H. G. Harley, A. J. Buckler, D. Church et al., Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member, Cell. 21 févr, vol.68, issue.4, pp.799-808, 1992.

A. Vautrin, Etude des dérégulations de l'épissage alternatif du pré-ARN messager de la troponine T cardiaque humaine associées aux dystrophies myotoniques de types 1 et 2 et des caractéristiques du facteur d'épissage MBNL1 impliqué dans ces pathologies, 2011.

E. W. Bush, C. S. Taft, G. E. Meixell, and M. B. Perryman, Overexpression of myotonic dystrophy kinase in BC3H1 cells induces the skeletal muscle phenotype, J Biol Chem. 5 janv, vol.271, issue.1, pp.548-52, 1996.

P. Kaliman, D. Catalucci, J. T. Lam, R. Kondo, J. Gutiérrez et al., Myotonic dystrophy protein kinase phosphorylates phospholamban and regulates calcium uptake in cardiomyocyte sarcoplasmic reticulum, J Biol Chem. 4 mars, vol.280, issue.9, pp.8016-8037, 2005.

, RCSB Protein Data Bank. protéine DMPK, 2015.

B. M. Davis, M. E. Mccurrach, K. L. Taneja, R. H. Singer, and D. E. Housman, Expansion of a CUG trinucleotide repeat in the 3' untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts, Proc Natl Acad Sci, vol.94, issue.14, pp.7388-93, 1997.

A. V. Philips, L. T. Timchenko, and T. A. Cooper, Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy, Science. 1 mai, vol.280, issue.5364, pp.737-778, 1998.

D. G. Wansink, R. Van-herpen, M. M. Coerwinkel-driessen, P. Groenen, B. A. Hemmings et al., Alternative Splicing Controls Myotonic Dystrophy Protein Kinase Structure, Enzymatic Activity, and Subcellular Localization, Mol Cell Biol. août, vol.23, issue.16, pp.5489-501, 2003.

R. S. Savkur, A. V. Philips, and T. A. Cooper, Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy, Nat Genet. sept, vol.29, issue.1, pp.40-47, 2001.

C. Savkur, R. S. Singh, G. Philips, A. V. Grice, E. A. Cooper et al., Loss of the Muscle-Specific Chloride Channel in Type 1 Myotonic Dystrophy Due to Misregulated Alternative Splicing, Mol Cell. 1 juill, vol.10, issue.1, pp.45-53, 2002.

M. B. Warf and J. A. Berglund, MBNL binds similar RNA structures in the CUG repeats of myotonic dystrophy and its pre-mRNA substrate cardiac troponin T, RNA N Y N. déc, vol.13, issue.12, pp.2238-51, 2007.

C. Carpentier, D. Ghanem, F. J. Fernandez-gomez, F. Jumeau, J. V. Philippe et al., Tau exon 2 responsive elements deregulated in myotonic dystrophy type I are proximal to exon 2 and synergistically regulated by MBNL1 and MBNL2, Biochim Biophys Acta. avr, vol.1842, issue.4, pp.654-64, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01453196

C. Fugier, A. F. Klein, C. Hammer, S. Vassilopoulos, Y. Ivarsson et al., Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy, Nat Med. juin, vol.17, issue.6, pp.720-725, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00811986

F. Rau, J. Lainé, L. Ramanoudjame, A. Ferry, L. Arandel et al., Abnormal splicing switch of DMD's penultimate exon compromises muscle fibre maintenance in myotonic dystrophy, Nat Commun. 28 mai, vol.6, p.7205, 2015.

F. Freyermuth, F. Rau, Y. Kokunai, T. Linke, C. Sellier et al., Splicing misregulation of SCN5A contributes to cardiac-conduction delay and heart arrhythmia in myotonic dystrophy, Nat Commun. 11 avr, vol.7, p.11067, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01301863

A. D. Otten and S. J. Tapscott, Triplet repeat expansion in myotonic dystrophy alters the adjacent chromatin structure, Proc Natl Acad Sci, vol.92, issue.12, pp.5465-5474, 1995.

F. Bouhour, M. Bost, and C. Vial,

, Presse Médicale Paris Fr 1983, juin, vol.36, issue.6, pp.965-71, 2007.

A. Ebralidze, Y. Wang, V. Petkova, K. Ebralidse, and R. P. Junghans, RNA leaching of transcription factors disrupts transcription in myotonic dystrophy, Science. 16 janv, vol.303, issue.5656, pp.383-390, 2004.

A. Pratte, C. Prévost, J. Puymirat, and J. Mathieu, Anticipation in myotonic dystrophy type 1 parents with small CTG expansions, Am J Med Genet A. avr, vol.167, issue.4, pp.708-722, 2015.

H. G. Brunner, H. T. Brüggenwirth, W. Nillesen, G. Jansen, B. Hamel et al., Influence of sex of the transmitting parent as well as of parental allele site on the CTG expansion in myotonic dystrophy (DM), Am J Hum Genet, vol.53, issue.5, pp.1016-1039, 1993.

H. G. Brunner, G. Jansen, W. Nillesen, M. R. Nelen, C. De-die et al., Reverse Mutation in Myotonic Dystrophy, N Engl J Med, vol.328, issue.7, pp.476-80, 1993.

S. De,

C. E. De-die-smulders, C. J. Höweler, C. Thijs, J. F. Mirandolle, H. B. Anten et al., Age and causes of death in adult-onset myotonic dystrophy, Brain J Neurol. août, vol.121, pp.1557-63, 1998.

C. Jaeger, . Dystrophie-myotonique-de-steinert, A. Myoline, and M. , , 1993.

J. Duda, Y. Venkatesh, and W. Groh, Causes and Predictors of Mortality in a Large U.S. Myotonic Dystrophy Type 1 Adult Cohort (P5.077), Neurology [Internet]. 5 avr, vol.86, issue.16, 2016.

R. Stojanovic, V. Peric, S. Paunic, T. Pavlovic, S. Cvitan et al., Cardiologic predictors of sudden death in patients with myotonic dystrophy type 1, J Clin Neurosci Off J Neurosurg Soc Australas. juill, vol.20, issue.7, pp.1002-1008, 2013.

A. Lazarus, J. Varin, D. Babuty, F. Anselme, J. Coste et al., Long-term follow-up of arrhythmias in patients with myotonic dystrophy treated by pacing: a multicenter diagnostic pacemaker study, J Am Coll Cardiol, vol.40, issue.9, pp.1645-52, 2002.

J. Mathieu, P. Allard, L. Potvin, C. Prévost, and P. Bégin, A 10-year study of mortality in a cohort of patients with myotonic dystrophy, Neurology. 12 mai, vol.52, issue.8, pp.1658-62, 1999.

M. F. Phillips and P. S. Harper, Cardiac disease in myotonic dystrophy, Cardiovasc Res. janv, vol.33, issue.1, pp.13-22, 1997.

G. Pelargonio, A. D. Russo, T. Sanna, D. Martino, G. Bellocci et al., Heart. déc, vol.88, issue.6, pp.665-70, 2002.

D. Bhakta, M. R. Lowe, and W. J. Groh, Prevalence of structural cardiac abnormalities in patients with myotonic dystrophy type I, Am Heart J. févr, vol.147, issue.2, pp.224-231, 2004.

D. Annane, P. Merlet, H. Radvanyi, B. Mazoyer, B. Eymard et al., Blunted coronary reserve in myotonic dystrophy. An early and gene-related phenomenon, Circulation. 1 sept, vol.94, issue.5, pp.973-980, 1996.

A. E. Epstein, J. P. Dimarco, K. A. Ellenbogen, N. Estes, R. A. Freedman et al., Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons, J Am Coll Cardiol. 27 mai, vol.51, issue.21, pp.1-62, 2008.

V. Laurent, S. Pellieux, P. Corcia, P. Magro, B. Pierre et al., Mortality in myotonic dystrophy patients in the area of prophylactic pacing devices, Int J Cardiol. 1 juill, vol.150, issue.1, pp.54-62, 2011.

K. Wahbi, C. Meune, R. Porcher, H. M. Bécane, A. Lazarus et al., Electrophysiological study with prophylactic pacing and survival in adults with myotonic dystrophy and conduction system disease, JAMA. 28 mars, vol.307, issue.12, pp.1292-301, 2012.

W. J. Groh, M. R. Groh, C. Saha, J. C. Kincaid, Z. Simmons et al., Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1, N Engl J Med. 19 juin, vol.358, issue.25, pp.2688-97, 2008.

P. Kaminsky, M. Poussel, L. Pruna, J. Deibener, B. Chenuel et al., Organ dysfunction and muscular disability in myotonic dystrophy type 1. Medicine (Baltimore), juill, vol.90, issue.4, pp.262-270, 2011.

P. Bégin, J. Mathieu, J. Almirall, and A. Grassino, Relationship between chronic hypercapnia and inspiratory-muscle weakness in myotonic dystrophy, Am J Respir Crit Care Med. juill, vol.156, issue.1, pp.133-142, 1997.

W. Pruzanski and A. Profis, Pulmonary disease in myotonic dystrophy, Am Rev Respir Dis. juin, vol.91, pp.874-883, 1965.

C. Thil, Réponse ventilatoire à la stimulation hypercapnique et fonction respiratoire dans la dystrophie myotonique de type I [Internet]. université de Lorraine nancy, 2015.

A. Modoni, G. Silvestri, M. G. Vita, D. Quaranta, P. A. Tonali et al., Cognitive impairment in myotonic dystrophy type 1 (DM1): a longitudinal follow-up study, J Neurol, vol.255, issue.11, pp.1737-1779, 2008.

J. S. Rubinsztein, D. C. Rubinsztein, S. Goodburn, and A. J. Holland, Apathy and hypersomnia are common features of myotonic dystrophy, J Neurol Neurosurg Psychiatry. avr, vol.64, issue.4, pp.510-515, 1998.

S. Peric, M. Sreckov, I. Basta, D. Lavrnic, M. Vujnic et al., Dependent and paranoid personality patterns in myotonic dystrophy type 1, Acta Neurol Scand. avr, vol.129, issue.4, pp.219-244, 2014.

H. Fujino, H. Shingaki, S. Suwazono, Y. Ueda, C. Wada et al., Cognitive impairment and quality of life in patients with myotonic dystrophy type 1. Muscle Nerve, 2017.

K. Okkersen, D. G. Monckton, N. Le, A. M. Tuladhar, J. Raaphorst et al., Brain imaging in myotonic dystrophy type 1: A systematic review, Neurology. 29 août, vol.89, issue.9, pp.960-969, 2017.
DOI : 10.1212/wnl.0000000000004300

URL : http://eprints.gla.ac.uk/141805/7/141805.pdf

M. C. Ørngreen, P. Arlien-søborg, M. Duno, J. M. Hertz, and J. Vissing, Endocrine function in 97 patients with myotonic dystrophy type 1, J Neurol. 1 mai, vol.259, issue.5, pp.912-932, 2012.

H. Fukazawa, T. Sakurada, K. Yoshida, N. Kaise, K. Kaise et al., Thyroid function in patients with myotonic dystrophy, Clin Endocrinol (Oxf). avr, vol.32, issue.4, pp.485-90, 1990.

J. E. Hilbert, R. J. Barohn, P. R. Clemens, E. A. Luebbe, W. B. Martens et al., High frequency of gastrointestinal manifestations in myotonic dystrophy type 1 and type 2, Neurology. 26 sept, vol.89, issue.13, pp.1348-54, 2017.

A. Achiron, Y. Barak, N. Magal, M. Shohat, M. Cohen et al., Abnormal liver test results in myotonic dystrophy, J Clin Gastroenterol. juin, vol.26, issue.4, pp.292-297, 1998.
DOI : 10.1097/00004836-199806000-00016

W. I. Verhagen, J. P. Ter-bruggen, and P. L. Huygen, Oculomotor, auditory, and vestibular responses in myotonic dystrophy, Arch Neurol. sept, vol.49, issue.9, pp.954-60, 1992.
DOI : 10.1001/archneur.1992.00530330078020

D. Boërio, J. Hogrel, G. Bassez, and J. Lefaucheur, Neuromuscular excitability properties in myotonic dystrophy type 1, Clin Neurophysiol Off J Int Fed Clin Neurophysiol, vol.118, issue.11, pp.2375-82, 2007.

S. Peric, V. R. Stojanovic, A. Nikolic, A. Kacar, I. Basta et al., Peripheral neuropathy in patients with myotonic dystrophy type 1, Neurol Res. mai, vol.35, issue.4, pp.331-336, 2013.
DOI : 10.1179/1743132812y.0000000144

C. M. Mueller, J. E. Hilbert, W. Martens, C. A. Thornton, R. T. Moxley et al., Hypothesis: neoplasms in myotonic dystrophy, Cancer Causes Control CCC. déc, vol.20, issue.10, pp.2009-2029, 2009.
DOI : 10.1007/s10552-009-9395-y

URL : http://europepmc.org/articles/pmc3110730?pdf=render

C. Dogan, D. Antonio, M. Hamroun, D. Varet, H. Fabbro et al., Gender as a Modifying Factor Influencing Myotonic Dystrophy Type 1 Phenotype Severity and Mortality: A Nationwide Multiple Databases Cross-Sectional Observational Study, PloS One, vol.11, issue.2, p.148264, 2016.
DOI : 10.1371/journal.pone.0148264

URL : https://hal.archives-ouvertes.fr/hal-01274908

D. Fialho, D. M. Kullmann, M. G. Hanna, and S. Schorge, Non-genomic effects of sex hormones on CLC-1 may contribute to gender differences in myotonia congenita, Neuromuscul Disord NMD, vol.18, issue.11, pp.869-72, 2008.

J. Mathieu, P. Allard, G. Gobeil, M. Girard, D. Braekeleer et al., Anesthetic and surgical complications in 219 cases of myotonic dystrophy, Neurology. déc, vol.49, issue.6, pp.1646-50, 1997.
DOI : 10.1212/wnl.49.6.1646

P. Kaminsky, J. F. Lesesve, P. Jonveaux, and L. Pruna, IgG deficiency and expansion of CTG repeats in myotonic dystrophy, Clin Neurol Neurosurg. juill, vol.113, issue.6, pp.464-472, 2011.
DOI : 10.1016/j.clineuro.2011.02.003

A. Koutsoulidou, M. Photiades, T. C. Kyriakides, K. Georgiou, M. Prokopi et al., Identification of Exosomal Muscle-Specific miRNAs in Serum of Myotonic Dystrophy Patients Relating to Muscle Disease Progress, Hum Mol Genet. 16 juin, 2017.

E. Fournier, &. Sémiologie-Élémentaire-de-l, and . Emg,

P. Kaminsky and L. Pruna, A genetic systemic disease: clinical description of type 1 myotonic dystrophy in adults

, Rev Med Interne. sept, vol.33, issue.9, pp.514-522, 2012.

I. Pénisson-besnier, , 1999.

A. Marteyn, Y. Maury, M. M. Gauthier, C. Lecuyer, R. Vernet et al., Mutant Human Embryonic Stem Cells Reveal Neurite and Synapse Formation Defects in Type 1 Myotonic Dystrophy, Cell Stem Cell. 8 avr, vol.8, issue.4, pp.434-478, 2011.

, AFM recherche

C. Thornton, etude observationnelle de dystrophie myotonique

U. Rochester, , 2017.

F. Guillemin, S. Brainçon, and J. Pourel,

, Rev Rhum Mal Osteoartic. juin, vol.58, issue.6, pp.459-65, 1991.

K. A. Vincent, A. J. Carr, J. Walburn, D. L. Scott, and M. R. Rose, Construction and validation of a quality of life questionnaire for neuromuscular disease (INQoL), Neurology. 27 mars, vol.68, issue.13, pp.1051-1058, 2007.

K. A. Ladonna, W. J. Koopman, and S. D. Venance, 04 Measuring quality of life in myotonic dystrophy type 1: A pilot study using the Individualized Neuromuscular Quality of Life questionnaire (INQoL), Neuromuscul Disord, vol.18, issue.9, p.744

S. Peric, C. Heatwole, E. Durovic, A. Kacar, A. Nikolic et al., Prospective measurement of quality of life in myotonic dystrophy type 1, Acta Neurol Scand. déc, vol.136, issue.6, pp.694-701, 2017.

C. Heatwole, R. Bode, N. E. Johnson, J. Dekdebrun, N. Dilek et al., Myotonic dystrophy health index: Correlations with clinical tests and patient function, Muscle Nerve. févr, vol.53, issue.2, pp.183-90, 2016.

C. Heatwole, R. Bode, N. Johnson, C. Quinn, W. Martens et al., Patient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1), Neurology. 24 juill, vol.79, issue.4, pp.348-57, 2012.

M. M. Axford and C. E. Pearson, Illuminating CNS and cognitive issues in myotonic dystrophy: Workshop report, Neuromuscul Disord. 1 avr, vol.23, issue.4, pp.370-374, 2013.

B. Brembilla-perrot, J. Schwartz, O. Huttin, Z. Frikha, J. M. Sellal et al., Atrial flutter or fibrillation is the most frequent and life-threatening arrhythmia in myotonic dystrophy, Pacing Clin Electrophysiol PACE. mars, vol.37, issue.3, pp.329-364, 2014.

, HAS. indications à la ventilation non invasive, 2013.

R. Development-core and . Team, R: A language and environment for statistical computing. R Foundation for Statistical Computing

H. A. Kahn, H. M. Leibowitz, J. P. Ganley, M. M. Kini, T. Colton et al., The Framingham Eye Study. I. Outline and major prevalence findings, Am J Epidemiol. juill, vol.106, issue.1, pp.17-32, 1977.

, Thyroid diseases in the SU.VI.MAX cohort Estimated incidence and related risk factors, 1994.

. Invs, Estimation de la prévalence du cancer en France métropolitaine chez les 15 ans et plus, 2008.

M. Poussel, P. Kaminsky, P. Renaud, J. Laroppe, L. Pruna et al., Supine changes in lung function correlate with chronic respiratory failure in myotonic dystrophy patients, Respir Physiol Neurobiol. 1 mars, vol.193, pp.43-51, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01712380

J. Mathieu, H. Boivin, and C. L. Richards, Quantitative motor assessment in myotonic dystrophy, Can J Neurol Sci J Can Sci Neurol. mai, vol.30, issue.2, pp.129-165, 2003.

E. Hammarén, G. Kjellby-wendt, and C. Lindberg, Muscle force, balance and falls in muscular impaired individuals with myotonic dystrophy type 1: a five-year prospective cohort study, Neuromuscul Disord NMD. févr, vol.25, issue.2, pp.141-149, 2015.